Glenn R. Mattes Insider Trading $ARNI Arno Therapeutics, Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Glenn R. Mattes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Glenn R. Mattes. Glenn R. Mattes is President & CEO in Arno Therapeutics, Inc ($ARNI) and President and CEO in TFF Pharmaceuticals, Inc. ($TFFP).
Glenn R. Mattes in Arno Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Glenn R. Mattes: President & CEO
Holdings: 77,203 shares
Current Value: $6,176
Latest Transaction: Jan 28 2014
$ARNI Market Capitalization: $4.19M
$ARNI Previous Close: $0.08
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Glenn R. Mattes in Arno Therapeutics, Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2014 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | A | 2.90 | 408,892 | 1,185,787 | 408,892 | |
| Nov 06 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | A | 2.40 | 386,697 | 928,073 | 386,697 | |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | P | 2.40 | 20,833 | 49,999 | 20,833 | |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | P | 4.00 | 20,833 | 83,332 | 20,833 | |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | A | 2.40 | 20,833 | 49,999 | 20,833 | |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | D | 2.40 | 20,833 | 49,999 | 0 | |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Option Exercise | C | 2.40 | 20,833 | 49,999 | 0 | |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | P | 0.00 | 20,833 | 0 | 77,203 | 56.4 K to 77.2 K (+36.96 %) |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Grant | A | 2.40 | 1,666 | 3,998 | 56,370 | 54.7 K to 56.4 K (+3.05 %) |
| Oct 31 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | C | 2.40 | 22,218 | 53,323 | 54,704 | 32.5 K to 54.7 K (+68.39 %) |
| May 30 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | J | 0.30 | 3,222 | 967 | 259,888 | 256.7 K to 259.9 K (+1.26 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | J | 0.30 | 3,333 | 1,000 | 256,666 | 253.3 K to 256.7 K (+1.32 %) |
| Apr 09 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | J | 0.30 | 3,333 | 1,000 | 253,333 | 250 K to 253.3 K (+1.33 %) |
Page: 1